Seattle Times (Free subscription) | 08/10/2009
Shares of Eli Lilly & Co. fell Monday after a Goldman Sachs analyst cut his rating on the drug developer to "Sell," citing the outlook for dwindling revenue and more spending to rebuild the product pipeline.
Market Watch (Free subscription) | 08/10/2009
BOSTON (MarketWatch0 -- Drug stocks joined the broader market in negative territory early Monday as shares of Eli Lilly & Co. fell on a downgrade by Goldman Sachs. The NYSE Arca Pharmaceutical Index eased 0.5% to 276.67 and the NYSE Arca Biotechnology Index declined 0.4% to 857.30. The Dow Jones Industrial Average slipped about 25 points to 9,345. Shares of Lilly were off 3% at $33.91. Goldman...
Volume Spike Investor (Free subscription) | 08/10/2009
Eli Lilly & Co. (NYSE: LLY) is getting a bad endorsement this morning. Goldman Sachs cut an already cautious rating down lower to a CONVICTION SELL. We have shares down 3.55% at $33.65 on 39,000 shares as of 8:51 AM EST. That will pick up in volume rapidly as we get closer to the open [...]
soulful sepulcher (Free subscription) | 08/05/2009
zyprexa prescribed to my daughter in 1999 off-label use in a child, caused 100 lb weight gainEli Lilly ‘Ghostwrote’ Articles to Market Zyprexa, Files Show- BloombergTHE ARTICLE-- "Eli Lilly & Co. officials wrote medical journal studies about the antipsychotic Zyprexa and then asked doctors to put their names on the articles, a practice called “ghostwriting,” according...
Miami Herald (Free subscription) | 08/04/2009
Eli Lilly & Co. said Tuesday it is offering buyouts to 4,000 U.S. sales representatives with the hope of eliminating a few hundred jobs.
Seattle Times (Free subscription) | 08/04/2009
Eli Lilly & Co. said Tuesday it is offering buyouts to 4,000 U.S. sales representatives with the hope of eliminating a few hundred jobs.
Trading Goddess Stock Blog! (Free subscription) | 07/31/2009
The stock trading technique called 'Buying Dividends' is becoming more and more popular. It is the process of buying stocks before the ex dividend date and selling the stock shortly after the ex date at about the same price, yet still being entitled to the dividend. This technique generally works only in bull markets. When you buy dividends , there are many stocks in many different sectors to choose...
West Virginia Record (Free subscription) | 07/29/2009
McGraw NEW YORK - State Attorney General Darrell McGraw and Eli Lilly & Co. apparently have reached a settlement, though the terms won't be known unless they are unsealed. Kenneth King, an attorney for the pharmaceuticals manufacturer, filed a notice Monday with U.S. District Judge Jack Weinstein notifying him that the two parties had agreed to dismiss the case. McGraw hired outside attorneys...
Business Wire (Free subscription) | 07/27/2009
NEW YORK--(BUSINESS WIRE)--Reportlinker.com announces that a new market research report is available in its catalogue. Reportlinker Adds Eli Lilly & Co.: PharmaVitae Profile
Market Wire (Free subscription) | 07/22/2009
NEW DELHI, INDIA (MARKET WIRE) Analyst Choice has combined some of the best financial and technical minds worldwide to bring you an array of free quality equity research and reporting. Today we have begun in-depth reporting on our website evaluating the current market condition of Hertz Global Holdings Inc. (NYSE: HTZ), American Oriental Bioengineering Inc. (NYSE: AOB), International Paper Co. (NYSE:...
NewsObserver.com - Business (Free subscription) | 07/22/2009
Eli Lilly & Co. said Wednesday its second-quarter profit rose 21 percent on stronger drug sales, leading the company to increase its full-year profit guidance.
San Fransisco Chronicle (Free subscription) | 07/22/2009
Eli Lilly & Co. said Wednesday its second-quarter profit rose 21 percent on stronger drug sales, leading the company to increase its full-year profit guidance. For the quarter, the Indianapolis company earned $1.16 billion, or $1.06 per share, up from $958.8...
Examiner (Free subscription) | 07/22/2009
Eli Lilly & Co. says its second-quarter profit rose 21 percent, and the drugmaker says its full-year profit will be better than expected.
Miami Herald (Free subscription) | 07/22/2009
Eli Lilly & Co. says its second-quarter profit rose 21 percent, and the drugmaker says its full-year profit will be better than expected.
Seattle Times (Free subscription) | 07/22/2009
Eli Lilly & Co. says its second-quarter profit rose 21 percent, and the drugmaker says its full-year profit will be better than expected.
The 2 latest articles published by users on Eli Lilly :
elvisdevon | 03/20/2009
The recent reports of Eli Lilly, the manufacturer of Cialis, have shown that things are looking pretty good for the weekend pill. And They seem to get even better in the future. Read more to find out why!
paisano1 | 03/17/2009
• SEC with a full case-study presentation as well as a full Q&A session with an SEC representative • 3M on successful SOX compliance in multi-national organizations • Eli Lilly on optimizing the external auditor relationship • Eastman Kodak Company on going beyond 404: Meeting the SOX governance requirements • Canadian Natural Resources on practical identification and mitigation of IT risks and controls
Videos